Magnesium chloride, nicotinamide, thiamine, vitamin b2, vitamin b6, zinc sulphate (Vitamag Forte)
Magnesium chloride, nicotinamide, thiamine, vitamin b2, vitamin b6, zinc sulphate
Acino Pharma (Pty) Ltd
Registration
- Applicant
- Acino Pharma (Pty) Ltd
- Registrations
- 1
Variants
| Product | Strength and form | Registration | Status | Schedule | Leaflets |
|---|---|---|---|---|---|
| Vitamag forte EACH TABLET CONTAINS MAGNESIUM CHLORIDE 670 mg NICOTINAMIDE 10 mg THIAMINE HYDROCHLORIDE 1 mg VITAMIN B2 1 mg VITAMIN B6 25 mg ZINC SULPHATE 17,6 mg | Not listed | 28023828/22.1/0238 | Registered | Not determined | None |
Regulatory status
This product is still scheduled by law even when this site could not determine which tier it falls under. The label carries the S number in a square border; ask a pharmacist if you need to know its schedule.
Listings for this ingredient that could not be applied to this product
S3: Vitamin b1
- and derivatives thereof
- in preparations thereof for injection; (S0)
- except in oral preparations or mixtures containing more than 100 mg of Vitamin B1 per recommended daily dose alone or in combination with other active pharmaceutical ingredients. (S1)
Consolidated Schedules 06 July 2026, lines 4392 to 4397
S3: Vitamin b2
- and derivatives thereof
- in preparations thereof for injection; (S0)
- except in oral preparations or mixtures containing more than 100 mg of Vitamin B2 per recommended daily dose alone or in combination with other active pharmaceutical ingredients. (S1)
Consolidated Schedules 06 July 2026, lines 4399 to 4404
S3: Vitamin b6
- and derivatives thereof
- in preparations thereof for injection; (S0)
- except in oral preparations or mixtures containing more than 100 mg of Vitamin B6 per recommended daily dose alone or in combination with other active pharmaceutical ingredients. (S1)
Consolidated Schedules 06 July 2026, lines 4421 to 4426
S1: Magnesium
- in oral preparations or mixtures containing more than 250 mg of Magnesium per recommended daily dose alone or in combination with other active pharmaceutical ingredients. (S0)
Consolidated Schedules 06 July 2026, lines 815 to 816
S1: Nicotinamide
- and derivatives thereof, in oral preparations or mixtures containing more than 500 mg of Nicotinamide per recommended daily dose alone or in combination with other active pharmaceutical ingredients. (S0)
Consolidated Schedules 06 July 2026, lines 886 to 888
S1: Vitamin b1
- and derivatives thereof
- in oral preparations or mixtures containing more than 100 mg of Vitamin B1 per recommended daily dose alone or in combination with other active pharmaceutical ingredients; (S0)
- except in preparations thereof for injection. (S3)
Consolidated Schedules 06 July 2026, lines 1149 to 1154
S1: Vitamin b2
- and derivatives thereof
- in oral preparations or mixtures containing more than 100 mg of Vitamin B2 per recommended daily dose alone or in combination with other active pharmaceutical ingredients; (S0)
- except in preparations thereof for injection. (S3)
Consolidated Schedules 06 July 2026, lines 1156 to 1161
S1: Vitamin b6
- and derivatives thereof
- in oral preparations or mixtures containing more than 100 mg of Vitamin B6 per recommended daily dose alone or in combination with other active pharmaceutical ingredients; (S0)
- except in preparations thereof for injection. (S3)
Consolidated Schedules 06 July 2026, lines 1170 to 1175
2 of 2 approved products with this ingredient carry S4 on their leaflet.
This is an informational summary of the Medicines and Related Substances Act 101 of 1965 and its 2017 General Regulations. It is not medical advice and not legal advice. Always check the medicine's label, which carries the schedule number inside a square border, or ask a pharmacist if you are unsure.
Combination product
This product contains more than one active ingredient, so it has no single molecular structure.
SAHPRA documents
SAHPRA has not published a professional information or patient information leaflet for this product.